Research and Clinical Trials
Search Cancer Clinical Trials
|Title||Safety Study of Live Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy|
|Disease/Condition||Phase 1¸ Organ Dysfunction¸ and Other Experimental|
|Description||This protocol will examine the safety of administration of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies. |
This pilot study will also investigate the safety of using a sepsis scoring system to determine when to initiate antibiotics in these patients.
|Eligibility Criteria||To be eligible for this study, patients must meet several criteria, including but not limited to the following:|
* Patient must be 18 Years and older
* Patient must have a diagnosed solid tumor malignancy.
* Patient has discussed this protocol and the risk associated with this study agent with an oncologist who is independent of this research.
* Patient is able to stay within 45 minutes driving time of Johns Hopkins Hospital for 28 days following discharge.
|Principal Investigator||Sanjay Goel, MD|
|Current Trial Type||Interventional|